New Diagnostics Using Recombinant DNA Technology
| Home | | Pharmaceutical Microbiology | | Pharmaceutical Microbiology |Chapter: Pharmaceutical Microbiology : Recombinant DNA Technology
For many years clinical diagnostic laboratories had limitations in the detection of pathogenic bacteria and parasites due to time constraints in the identification of these agents, as they required to be cultured, a time-consuming procedure detrimental to the patients’ health.
NEW
DIAGNOSTICS USING RECOMBINANT DNA TECHNOLOGY
For many years clinical
diagnostic laboratories had limitations in the
detection of pathogenic bacteria and parasites due to time
constraints in the
identification of these agents, as they
required to be cultured, a time-consuming
procedure detrimental to the patients’
health. In addition, many inherited genetic
disorders could not
be identified owing to the lack of appropriate techniques and the unavailability
of the human genome sequence. The rapid developments
in molecular biology
have enabled modern
medicine to overcome some of these problems. Currently, a good diagnostic test must be specific
for a target
molecule, sensitive enough to detect minute
levels of that molecule, rapid and technically simple.
Related Topics
